Literature DB >> 15963932

Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization.

John R Greenland1, Huining Liu, David Berry, Daniel G Anderson, Woong-Ki Kim, Darrell J Irvine, Robert Langer, Norman L Letvin.   

Abstract

Increased in vivo expression of intramuscularly delivered plasmid DNA will be essential for clinical success in gene therapy and plasmid DNA vaccination. We screened polymers from a library of beta-amino esters for their ability to augment transgene expression as measured by beta-galactosidase activity and cellular immune responses. Among the candidates identified in this screen, poly[(1,6-di(acryloxyethoxy)hexane)-co-(4-aminobutanol)] enhanced plasmid DNA transgene expression by sevenfold (P=0.0001) and its immunogenicity by 70% (P=0.03). We found that polymers with moderately hydrophobic backbones and terminal alcohol groups facilitated transfection most effectively in vivo. We also observed a log-linear correlation (R2=0.93) between peak cellular immune responses and transgene activity in all evaluated polymer-plasmid DNA formulations, clarifying the relationship between immunogenicity and the quantity of expressed antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963932     DOI: 10.1016/j.ymthe.2005.01.021

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  20 in total

1.  Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis.

Authors:  John R Greenland; Ralf Geiben; Sharmistha Ghosh; William A Pastor; Norman L Letvin
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

2.  Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

3.  Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery.

Authors:  Lane V Christensen; Chien-Wen Chang; James W Yockman; Rafe Conners; Heidi Jackson; Zhiyuan Zhong; Jan Feijen; David A Bull; Sung Wan Kim
Journal:  J Control Release       Date:  2006-12-28       Impact factor: 9.776

4.  CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Nico van Rooijen; Avi-Hai Hovav; Norman L Letvin
Journal:  Blood       Date:  2008-09-10       Impact factor: 22.113

5.  Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

6.  Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polycation chain-length.

Authors:  Rupei Tang; R Noelle Palumbo; Lakshmi Nagarajan; Emily Krogstad; Chun Wang
Journal:  J Control Release       Date:  2009-10-27       Impact factor: 9.776

7.  Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.

Authors:  Panagiotis Mastorakos; Clark Zhang; Eric Song; Young Eun Kim; Hee Won Park; Sneha Berry; Won Kyu Choi; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2017-07-08       Impact factor: 9.776

Review 8.  Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases.

Authors:  Meghna Talekar; Thanh-Huyen Tran; Mansoor Amiji
Journal:  AAPS J       Date:  2015-04-29       Impact factor: 4.009

9.  Polymer multilayer tattooing for enhanced DNA vaccination.

Authors:  Peter C DeMuth; Younjin Min; Bonnie Huang; Joshua A Kramer; Andrew D Miller; Dan H Barouch; Paula T Hammond; Darrell J Irvine
Journal:  Nat Mater       Date:  2013-01-27       Impact factor: 43.841

10.  Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Camila Santucci; Brian Tran; Robert Langer; Gregory T Zugates; Daniel G Anderson; Richard S Kornbluth
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.